Andrew C. McCreary,Gustaaf J. M. Van Scharrenburg,Martinus Th. M. Tulp
申请号：
US11762239
公开号：
US08106056B2
申请日:
2007.06.13
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a composition containing bifeprunox or its N-oxide, or at least one pharmacologically acceptable salt thereof:and L-DOPA or at least one pharmacologically acceptable salt thereof, for simultaneous, separate or sequential use in the treatment of disorders requiring recovery of dopaminergic function, including Parkinsons disease and restless leg syndrome.
